Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevalence, Characteristics and Prognosis of Transthyretin Amyloidosis in Patients With New-onset Advanced AV-block - A National Screening Study

NCT05699044 is registered in ClinicalTrials.gov with Steen Hvitfeldt Poulsen as lead sponsor.

NCT NCT05699044
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05699044 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevalence, Characteristics and Prognosis of Transthyretin Amyloidosis in Patients With New-onset Advanced AV-block - A National Screening Study
Lead sponsor
Steen Hvitfeldt Poulsen
Phase
Observational
Overall status
Unknown status
Start date
October 1, 2022
Completion date
October 1, 2025
Enrollment
170 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amyloid cardiomyopathy, block, av